本页面由Tiger Trade Technology Pte. Ltd.提供服务

Summit Therapeutics PLC

17.55
+0.55003.24%
盘前18.250.7000+3.99%05:17 EDT
成交量:427.81万
成交额:7,493.63万
市值:140.01亿
市盈率:-15.70
高:17.70
开:17.20
低:17.14
收:17.00
52周最高:29.23
52周最低:12.07
股本:7.98亿
流通股本:1.52亿
量比:0.56
换手率:2.81%
股息:- -
股息率:- -
每股收益(TTM):-1.1177
每股收益(LYR):-1.4439
净资产收益率:-192.50%
总资产收益率:-101.61%
市净率:22.22
市盈率(LYR):-12.15

数据加载中...

2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

SEC问询函

[Cover]Correspondence
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露报告

General statement of acquisition of beneficial ownership
2019/01/18

非美公司披露报告

Notice of Exempt Offering of Securities, item 06b
2019/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/22

非美公司披露报告

2018/10/09

非美公司披露报告

2018/09/20

非美公司披露报告